<--- Back to Details
First PageDocument Content
Peptide hormones / Growth factors / Osphronemidae / Laboratory techniques / Molecular biology / Insulin-like growth factor 1 receptor / Insulin-like growth factor 1 / Insulin-like growth factor / Phosphoinositide 3-kinase / Growth hormone treatment / Insulin / Giant gourami
Date: 2016-03-06 17:13:22
Peptide hormones
Growth factors
Osphronemidae
Laboratory techniques
Molecular biology
Insulin-like growth factor 1 receptor
Insulin-like growth factor 1
Insulin-like growth factor
Phosphoinositide 3-kinase
Growth hormone treatment
Insulin
Giant gourami

Molecular cloning and sequence analysis of insulin-like growth factors-1 cDNA of giant gourami, Osphronemus goramy 1 Irmawati, 2Alimuddin, 2Muhammad Zairin, 2Muhammad A. Suprayudi,

Add to Reading List

Source URL: www.bioflux.com.ro

Download Document from Source Website

File Size: 591,46 KB

Share Document on Facebook

Similar Documents

Long-term culture of muscle explants from Sparus aurata

Long-term culture of muscle explants from Sparus aurata

DocID: 1rnjp - View Document

Effects of isoflavones on mRNA expression of IGF1, IGF2, EGF and related growth factor receptors in porcine muscle satellite cell cultures

Effects of isoflavones on mRNA expression of IGF1, IGF2, EGF and related growth factor receptors in porcine muscle satellite cell cultures

DocID: 1pJoc - View Document

NIH Public Access Author Manuscript Trends Pharmacol Sci. Author manuscript; available in PMC 2011 February 1. NIH-PA Author Manuscript

NIH Public Access Author Manuscript Trends Pharmacol Sci. Author manuscript; available in PMC 2011 February 1. NIH-PA Author Manuscript

DocID: 1pmIV - View Document

Molecular cloning and sequence analysis of insulin-like growth factors-1 cDNA of giant gourami, Osphronemus goramy 1  Irmawati, 2Alimuddin, 2Muhammad Zairin, 2Muhammad A. Suprayudi,

Molecular cloning and sequence analysis of insulin-like growth factors-1 cDNA of giant gourami, Osphronemus goramy 1 Irmawati, 2Alimuddin, 2Muhammad Zairin, 2Muhammad A. Suprayudi,

DocID: 1oPCb - View Document

Retraction Pfizer, Inc., has recently learned that the overall response rate and progression-free survival data published in “Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871

Retraction Pfizer, Inc., has recently learned that the overall response rate and progression-free survival data published in “Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871

DocID: 1bNWC - View Document